Tag

Ldl

All articles tagged with #ldl

Five Statin Myths Debunked: What Science Says About Cholesterol Drugs
health12 days ago

Five Statin Myths Debunked: What Science Says About Cholesterol Drugs

A comprehensive look at common statin myths: large randomized trials show muscle pain is largely a nocebo effect, with true statin-related pain being rare; any diabetes risk from statins is small in absolute terms (low-dose increases ~0.12% per year, high-dose ~1.27% per year) and outweighed by big reductions in heart attacks and strokes; memory loss and liver damage are not proven causal effects and serious liver injury is extremely rare; and the greatest benefit comes from combining statins with healthy lifestyle changes. High-dose statins can lower LDL by about 50% and, when paired with lifestyle improvements, significantly reduce cardiovascular risk.

New cholesterol guidelines push earlier, personalized heart-disease prevention
health-and-medicine13 days ago

New cholesterol guidelines push earlier, personalized heart-disease prevention

The 2026 ACC/AHA dyslipidemia guidelines call for earlier, more personalized cholesterol screening (even in children for familial hypercholesterolemia), broader risk assessment including genetic factors like Lp(a), and introduce a new PREVENT calculator to estimate 10- and 30-year cardiovascular risk, with expanded treatment options and lower LDL targets to prevent heart disease decades down the line.

New Cholesterol Guidelines Emphasize Early Screening and Clear LDL Goals
health14 days ago

New Cholesterol Guidelines Emphasize Early Screening and Clear LDL Goals

The 2026 cholesterol guidelines from the ACC and AHA expand risk assessment to ages 30–79, emphasize lifetime risk, restore explicit LDL targets (<100 mg/dL for low risk, <70 mg/dL for higher risk, <55 mg/dL for very high risk), add one-time Lp(a) testing to uncover genetic risk, and encourage earlier lifestyle changes and targeted therapies to prevent heart disease.

Oral PCSK9 Pill Cuts LDL Cholesterol by Up to 60% in Phase 3 Trial
health24 days ago

Oral PCSK9 Pill Cuts LDL Cholesterol by Up to 60% in Phase 3 Trial

A phase 3 trial of the daily oral PCSK9 inhibitor enlicitide showed LDL cholesterol falls by about 60% in 2,909 patients with atherosclerosis or high cardiovascular risk, many already on statins. The pill also reduced non-HDL cholesterol, apolipoprotein B, and lipoprotein(a), with effects lasting one year. If FDA approves, enlicitide could offer an oral alternative to injectable PCSK9 therapies and improve adherence, though a separate study is needed to confirm whether these LDL reductions translate into fewer heart attacks and strokes. The trial was Merck-funded and ongoing work aims to determine cardiovascular event outcomes.

Cholesterol guidelines urge earlier screening and expanded biomarker testing
health28 days ago

Cholesterol guidelines urge earlier screening and expanded biomarker testing

New cholesterol guidelines urge starting screening in your 30s and using lifetime risk (via the PREVENT calculator) alongside 10-year risk to guide treatment. Targets are LDL <100 mg/dL for most, <70 mg/dL for high-risk individuals, and <55 mg/dL for those with existing heart disease, with statins considered earlier; the guidance also recommends apoB testing after LDL goals and universal lipoprotein(a) testing once in adulthood, plus calcium scoring for those at borderline/intermediate risk, all aiming to reduce lifetime LDL exposure and prevent cardiovascular events.

Early Lipid-Lowering Urged: New Guidelines Target 30-Year-Olds
health28 days ago

Early Lipid-Lowering Urged: New Guidelines Target 30-Year-Olds

New cardiovascular guidelines urge starting lipid management as early as age 30, using the PREVENT risk calculator and lower LDL targets (under 100 mg/dL for lower-risk, under 70 mg/dL for high risk, and under 55 mg/dL for very high risk). They endorse lifestyle changes, consider coronary calcium scans and biomarkers like Lp(a) and ApoB to guide therapy, and include statins and, in some cases, PCSK9 inhibitors as part of a broader prevention strategy.

Two-Day Oat Diet Lowers LDL Cholesterol, Possibly via Gut Bacteria
health1 month ago

Two-Day Oat Diet Lowers LDL Cholesterol, Possibly via Gut Bacteria

In a small study of adults with metabolic syndrome, participants ate 100 g of rolled oats three times daily for 48 hours and saw total cholesterol fall about 8% and LDL drop around 10%, with these effects persisting six weeks after returning to their usual diet. Researchers suggest the changes may stem from gut bacteria metabolizing oats into compounds like ferulic acid that improve cholesterol metabolism. A longer six-week oats-only trial produced smaller, slower benefits. Larger studies are needed to confirm the findings.

High-Dose Oats Over 2 Days Cut LDL by 10%, Study Finds
health2 months ago

High-Dose Oats Over 2 Days Cut LDL by 10%, Study Finds

Two parallel randomized trials found that a two-day oatmeal-only diet lowered LDL and total cholesterol by about 10% with effects lasting six weeks, while six weeks of replacing one daily meal with oats did not change cholesterol. The benefit is linked to rapid gut microbiome shifts and oat phenolics from a high-dose oat exposure, suggesting short, intensive oat interventions may aid cholesterol management but are not a substitute for an overall heart-healthy diet.

Oats for two days cut LDL cholesterol in Bonn study
health2 months ago

Oats for two days cut LDL cholesterol in Bonn study

In a University of Bonn study, 32 adults with metabolic syndrome followed a calorie-restricted, oat-heavy breakfast for two days. LDL cholesterol fell about 10% within 48 hours, participants lost about 2 kg (4.5 lb), and blood pressure dipped slightly; the cholesterol reduction persisted for six weeks after returning to their usual Western diet, likely via gut bacteria metabolizing oats and producing metabolites that help cholesterol metabolism.

health2 months ago

Cardiologist debunks eight cholesterol myths

A consultant cardiologist busts eight common cholesterol myths, stressing that slim people can have high LDL, total cholesterol alone isn’t a reliable risk measure, and that cholesterol levels change with age and menopause; familial hypercholesterolaemia can cause early heart disease, HDL isn’t always protective, dietary cholesterol like eggs has a smaller impact than saturated fat, and statins aren’t a license to splurge on unhealthy foods. For management, doctors rely on detailed lipid profiles (TC, LDL, HDL, triglycerides) and risk scores, with diet helping but often medication needed.

health-and-medicine6 months ago

Inflammation Surpasses Cholesterol in Predicting Heart Disease, Says ACC

Recent research suggests inflammation may be a stronger predictor of heart disease than cholesterol levels, with inflammation markers like hs-CRP gaining attention. While LDL cholesterol remains a useful biomarker, it is not the sole factor in cardiovascular risk, especially since many heart attack patients have normal LDL levels. The article emphasizes the importance of considering inflammation and lifestyle factors alongside traditional cholesterol measures for a comprehensive approach to heart health.